Worldwide legislative challenges related to psychoactive drugs


NEGREI C., GALATEANU B., STAN M., BALALAU C., DUMITRU M. L. B., Ozcagli E., ...Daha Fazla

DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, cilt.25, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 25
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1186/s40199-017-0180-2
  • Dergi Adı: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: "New" psychoactive substances, Regulatory, Control systems, Legislation, BUPRENORPHINE, SUBSTANCES
  • İstanbul Üniversitesi Adresli: Evet

Özet

The discovery of a "new" psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances.